Rifaximin is a semi-synthetic derivative of rifampin and acts by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase blocking one of the steps in transcription. This results in ...

XIFAXAN® is approved for the reduction of overt hepatic encephalopathy recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea in adults. With a robust gross profit ...

Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off more than 150 Safeway corporate workers. Inside Beauty spoke to Jamie Sachs, vice president ...

Bausch Health (BHC) Companies and Salix Pharmaceuticals acknowledged that the Centers for Medicare and Medicaid Services has selected XIFAXAN 550 mg tablets as one of the medicines for the second ...

We look forward to engaging in open and transparent conversations with CMS, where we will share information on the value that XIFAXAN® delivers for the healthcare system in addition to sharing ...